[HTML][HTML] Effect of different disease-modifying therapies on humoral response to BNT162b2 vaccine in Sardinian multiple sclerosis patients
M Pitzalis, ML Idda, V Lodde, A Loizedda… - Frontiers in …, 2021 - frontiersin.org
Objectives Vaccination against COVID-19 is highly recommended to patients affected by
multiple sclerosis (MS); however, the impact of MS disease-modifying therapies (DMTs) on …
multiple sclerosis (MS); however, the impact of MS disease-modifying therapies (DMTs) on …
Classical and alternative receptors for SARS‐CoV‐2 therapeutic strategy
Understanding the molecules that are essential for severe acute respiratory syndrome
coronavirus‐2 (SARS‐CoV‐2) entry can provide insights into viral infection and …
coronavirus‐2 (SARS‐CoV‐2) entry can provide insights into viral infection and …
Update on therapeutic approaches and emerging therapies for SARS-CoV-2 virus
The global pandemic of coronavirus disease 2019 (COVID-19), caused by novel severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in over 7,273,958 …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in over 7,273,958 …
[HTML][HTML] Artificial intelligence in surveillance, diagnosis, drug discovery and vaccine development against COVID-19
As of August 6th, 2021, the World Health Organization has notified 200.8 million laboratory-
confirmed infections and 4.26 million deaths from COVID-19, making it the worst pandemic …
confirmed infections and 4.26 million deaths from COVID-19, making it the worst pandemic …
[PDF][PDF] Single-cell analysis of COVID-19, sepsis, and HIV infection reveals hyperinflammatory and immunosuppressive signatures in monocytes
The mortality risk of coronavirus disease 2019 (COVID-19) patients has been linked to the
cytokine storm caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
cytokine storm caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
[HTML][HTML] Persistent systemic microbial translocation and intestinal damage during coronavirus disease-19
A Oliva, MC Miele, F Di Timoteo, M De Angelis… - Frontiers in …, 2021 - frontiersin.org
Microbial translocation (MT) and intestinal damage (ID) are poorly explored in COVID-19.
Aims were to assess whether alteration of gut permeability and cell integrity characterize …
Aims were to assess whether alteration of gut permeability and cell integrity characterize …
COVID‐19 pathogenesis, prognostic factors, and treatment strategy: Urgent recommendations
B Zhou, S Kojima, A Kawamoto… - Journal of medical …, 2021 - Wiley Online Library
The pandemic of novel coronavirus disease (COVID‐19) is not yet close to being over, more
than 8 months after the first cases, but researchers are making great progress in fighting the …
than 8 months after the first cases, but researchers are making great progress in fighting the …
[HTML][HTML] Incidence of thrombosis and hemorrhage in hospitalized cancer patients with COVID‐19
Abstract Background Coronavirus disease‐2019 (COVID‐19) is a recognized prothrombotic
state. Patients hospitalized with active cancer are predisposed to thrombosis but whether …
state. Patients hospitalized with active cancer are predisposed to thrombosis but whether …
How SARS-CoV-2 (COVID-19) spreads within infected hosts—what we know so far
S Sanyal - Emerging topics in life sciences, 2020 - portlandpress.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the
ongoing pandemic of coronavirus disease 2019 (COVID-19), belongs to the betacoronavirus …
ongoing pandemic of coronavirus disease 2019 (COVID-19), belongs to the betacoronavirus …
[HTML][HTML] Dynamic blood single-cell immune responses in patients with COVID-19
L Huang, Y Shi, B Gong, L Jiang, Z Zhang… - Signal transduction and …, 2021 - nature.com
Abstract The 2019 coronavirus disease (COVID-19) outbreak caused by the SARS-CoV-2
virus is an ongoing global health emergency. However, the virus' pathogenesis remains …
virus is an ongoing global health emergency. However, the virus' pathogenesis remains …